| CASE REPORT |
|
| Year : 2022 | Volume
: 4
| Issue : 1 | Page : 15 |
|
|
Use of the dexamethasone implant as an adjunct in the treatment of Coats disease in a pediatric patient
Salcedo Hugo Ricardo1, M Vasquez Fitha2, Lalaleo Elvia Mariana3
1 Instituto de Oftalmología y Glaucoma Vásquez, Quito, Retina Division, Ecuador
2 Pediatric Ophthalmology and Strabismus Department, Centro Medico Axxis, Quito, Ecuador
3 General Ophthalmology, Centro Médico Vista Integral, Quito, Ecuador
Correspondence Address:
Dr. Salcedo Hugo Ricardo
Jardines del Batán, Edificio Semirabad, Quito
Ecuador
 Source of Support: None, Conflict of Interest: None
DOI: 10.4103/pajo.pajo_125_21
|
|
|
To report the use of intravitreal dexamethasone implant and its short-term efficacy in a pediatric patient with Coats' disease. A 7-year-old patient was referred to the clinic because of decreased visual acuity in the right eye of 10-month duration. Best-corrected visual acuity was 20/400. Funduscopic examination showed evidence of Stage 2B Coats' disease. The patient underwent treatment with laser photocoagulation, intravitreal injection of bevacizumab, and intravitreal injection of dexamethasone implant. During the 10-month follow-up, there was no evidence of side effects. Anatomical resolution was evident on funduscopic examination and macular optical coherence tomography, with best-corrected visual acuity being 20/60. Intravitreal dexamethasone implant was effective during the 10-month follow-up; providing improvement in visual acuity without any side effects.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
